Communiqués Labcorp Holdings Inc.

Actions

LH

US5049221055

Installations et services en soins de santé

Temps réel estimé 20:55:27 20/08/2026 Varia. 5j. Varia. 1 janv.
332,91 USD +0,75% Graphique intraday de Labcorp Holdings Inc. +3,26% +32,78%

Communiqués

18/08 Labcorp and NACHC Launch Strategic Alliance to Strengthen Health Center Leadership and Advance Community Health PR
17/08 Labcorp to Host Investor Day on September 10, 2026 PR
10/08 Labcorp Announces FDA Approval of Companion Diagnostic Supporting Patients with Advanced Melanoma PR
04/08 Labcorp Launches FDA-Approved PTEN Companion Diagnostic for Prostate Cancer PR
30/07 Labcorp: Q2 Earnings Snapshot AQ
30/07 Labcorp Announces 2026 Second Quarter Results; Raises Full Year 2026 Guidance PR
27/07 Labcorp Launches Marker by Labcorp™ Genetic Health Panel, Expanding Consumer Access to Hereditary Genetic Risk Testing PR
09/07 Labcorp Declares Quarterly Dividend PR
30/06 Labcorp to Announce Second Quarter 2026 Financial Results on July 30, 2026 PR
23/06 Labcorp Announces Nationwide Availability of ColoSense(R), the First FDA-Approved RNA-Based At-Home Colorectal Cancer Screening Test AQ
22/06 Labcorp Announces Nationwide Availability of ColoSense®, the First FDA-Approved RNA-Based At-Home Colorectal Cancer Screening Test PR
29/05 Labcorp Supports Multi-Institution Trial to Expand Genetic Testing in Colorectal Cancer PR
28/05 Labcorp Launches Expanded DPYD Test to Identify Cancer Patients at Risk for Severe Chemotherapy Side Effects PR
27/05 Labcorp to Present at the Jefferies Global Healthcare Conference PR
20/05 Labcorp Launches MyLabcorp™, a New AI-Powered Mobile App Designed to Help Consumers Understand Lab Results and Track Health Trends Over Time PR
12/05 Labcorp and Epic Expand Collaboration to Advance Diagnostic Integration across Hospitals and Health Systems PR
07/05 Labcorp : Publishes 2025 Corporate Responsibility Report, Highlighting Progress in Sustainability, Access to Care and Employee Well-Being PU
01/05 Labcorp : Corporate Responsibility Report (2001700-0326-1 BRO Corporate%20responsibility%20report%202025 FINAL) PU
30/04 Labcorp: Q1 Earnings Snapshot AQ
30/04 Labcorp Announces 2026 First Quarter Results; Raises Full Year 2026 Guidance PR
22/04 Labcorp Launches FDA-Approved Companion Diagnostic to Identify Patients with Ovarian Cancer Eligible for KEYTRUDA® PR
15/04 Labcorp Launches FDA-Cleared Fentanyl Test Delivering Results in 10 Minutes PR
14/04 Labcorp Introduces AI-Powered Real-World Data Platform with AWS and Datavant to Accelerate Alzheimer's Research PR
13/04 Children's Hospital of Philadelphia and Labcorp Announce a Collaboration to Accelerate Access to Advanced Pediatric Diagnostics Nationwide PR
09/04 Labcorp Declares Quarterly Dividend PR
Aucun résultat pour cette recherche